[Effects of adenosine 3',5'-cyclic monophosphate (cyclic AMP) on the circulatory system and renal function].
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D000242:Cyclic AMP / Q000494:pharmacology; D004285:Dogs; D005919:Glomerular Filtration Rate; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007668:Kidney / Q000098:blood supply / Q000187:drug effects*; D007677:Kidney Function Tests; D010424:Pentobarbital / Q000494:pharmacology; D011188:Potassium / Q000652:urine; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012964:Sodium / Q000652:urine; D014554:Urination / Q000187:drug effects
D000227:Adenine Nucleotides; D006493:Heparin; D012964:Sodium; D000242:Cyclic AMP; D010424:Pentobarbital; D011188:Potassium